CJ
BCYC

Caitlin John’s Bicycle Therapeutics BCYC Stock Holding History

Caitlin John’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9 Hold
2
– – ﹤0.01% 934
2025
Q4 		$14 Hold
2
– – ﹤0.01% 922
2025
Q3 		$15 Buy
+2
New +$15 ﹤0.01% 879
2025
Q1 		– Sell
-14
Closed -$196 – 186
2024
Q4 		$196 Hold
14
– – ﹤0.01% 819
2024
Q3 		$325 Hold
14
– – ﹤0.01% 794
2024
Q2 		$283 Buy
+14
New +$316 ﹤0.01% 798

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caitlin John's BCYC Position: Q1 2026 in Review

Caitlin John held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 2 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Caitlin John first reported a position in BCYC in Q2 2024 and has held it in 6 quarters since. The position peaked at $325 in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Caitlin John held 2 shares of Bicycle Therapeutics worth $9 as of Q1 2026.
  • Caitlin John left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #934 holding.
  • Caitlin John first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Caitlin John's Bicycle Therapeutics position peaked at $325 in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.